The possibility of using the CH–SA–HA polysaccharide construct in a clinical setting in patients aged 18–35 years with type I diabetes mellitus and a diagnosis of chronic widespread periodontitis with a duration of no more than 3 years is cited in earlier studies [41,73]. This evidence concerns the gene C4B and type 1 diabetes mellitus.